|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/635 |
| (11) | Patento numeris | 1355631 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01965984.6 |
| Europos patento paraiškos padavimo data | 2001-08-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-10-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-10-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2001/025803 |
| Data | 2001-08-17 |
| (87) | Numeris | WO 2002/015885 |
| Data | 2002-02-28 |
| (30) | Numeris | Data | Šalis |
| 226347 P | 2000-08-18 | US |
| (72) |
LE, Trang, T., US
KARARLI, Tugrul, T., US
KONTNY, Mark, J., US
SASTRY, Srikonda, V., US
NYSHADHAM, Janaki, R., US
PAGLIERO, Arthur, J., Jr., US
|
| (73) |
Pharmacia Corporation,
100 Route 206 North, Peapack, NJ 07977,
US
Astellas Pharma Technologies, Inc., 1050 Arastradero Road, Palo Alto, CA 94304, US |
| (54) | ORAL FAST-MELT FORMULATION OF A CYCLOOXYGENASE-2 INHIBITOR |
| ORAL FAST-MELT FORMULATION OF A CYCLOOXYGENASE-2 INHIBITOR |